Naseem Ali, medical affairs lead for XTANDI at Astellas Australia, said, “Prostate cancer is currently the most diagnosed cancer in Australia and continues to be a major health burden, but these findings signal a meaningful step forward in improving outcomes for men facing the disease."
Australian-led ENZAMET prostate cancer trial to be presented at ASCO 2025
May 27, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
PYC to present early polycystic kidney disease trial data at US nephrology conference
October 7, 2026 - - Australian Biotech -
CSL raises US$1.5 billion from US bond investors to refinance debt
October 7, 2026 - - Latest News -
Every serious attempt to reform PBS pricing has run into the same problem
October 7, 2026 - - Latest News -
AFT reaffirms profit guidance as its R&D pipeline moves toward 2029 launches
October 7, 2026 - - Latest News -
The patient who knows what they want is informed and not a danger
October 7, 2026 - - Latest News -
TGA turns to national security surveillance platform to police therapeutic goods compliance
October 6, 2026 - - Latest News -
Company size shapes CEO pay trends in Australian health care and biotechnology
October 6, 2026 - - Latest News
